Brain Pathology in the Collagen Vascular Diseases

Budka, Herbert
June 1981
Angiology;Jun1981, Vol. 32 Issue 6, p365
Academic Journal
This article focuses on brain pathology in the collagen vascular diseases. Among vascular diseases affecting the central nervous system (CNS), inflammatory disorders of the cerebral vessels have met increasing clinical interest in the last years. When infectious angiitides are excluded, the majority of cerebral vasculitides usually classified among the connective tissue disorders or collagen vascular diseases. CNS involvement in systemic forms like in the prototype of this disease group, systemic lupus erythematodes, is a common, difficult, and frequently emerging problem and often may be the cause of death. In this article, some morphologic evidence of immunopathologic damage of small vessels as cause of primary CNS lesions will be presented from histologic and immunocytochemical studies.


Related Articles

  • CD13/aminopeptidase N in collagen vascular diseases. Dan, Hirohumi; Tani, Kenji; Hase, Kayoko; Shimizu, Teruki; Tamiya, Hiroyuki; Biraa, Yanjmaa; Luping Huang; Yanagawa, Hiroaki; Sone, Saburo // Rheumatology International;Nov2003, Vol. 23 Issue 6, p271 

    To determine the significance of CD13/aminopeptidase N in collagen vascular diseases (CVD), we examined its activity and expression in sera and disease sites of patients with CVD. Significantly higher aminopeptidase activity was detected in bronchoalveolar lavage fluid from patients with...

  • Erratum.  // Rheumatology;Feb2008, Vol. 47 Issue 2, p234 

    Corrections to articles on connective tissue diseases and rheumatology that were published in supplement to the journal's 2006 issue are presented.

  • t-PA, PAI, and Protein C Before and After Vascular Occlusion of the Upper Limb in Patients with Raynaud's Phenomenon. Cimminiello, Claudio; Milani, Massimo; Uberti, Tiziano; Arpaia, Guido; Motta, Adele; Bonfardeci, Giuseppe // Angiology;Mar1991, Vol. 42 Issue 3, p231 

    Tissue plasminogen activator (t-PA) and its inhibitor (PAI) were assessed in venous blood drawn before and after venous occlusion (bvo, avo) for 33 patients with Raynaud's phenomenon (RP), 14 with primary RP (PRP), 9 with suspected secondary RP (SSRP), and 10 with definite collagen disease and...

  • Systemic Sclerosis.  // Current Medical Literature: Rheumatology;2003, Vol. 22 Issue 4, p101 

    Presents a critique on articles regarding systemic sclerosis published in various medical literature. Increased levels of serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha in systemic sclerosis patients; Risk of cancer in scleroderma patient;...

  • Systemic Lupus Erythematosus.  // Current Medical Literature: Rheumatology;2003, Vol. 22 Issue 4, p102 

    Presents a critique on articles about systemic lupus erythematosus published in various medical literature. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I immunoglobulin G antibodies; Correlation of Y chromosome microchimerism with disease...

  • Surgical management of tophaceous gout in the hand. Ertu&gcaron;rul Şener, E.; Güzel, Volkan B.; Takka, Semih // Archives of Orthopaedic & Trauma Surgery;Jul2000, Vol. 120 Issue 7/8, p482 

    A patient who suffered from severe deforming arthritis secondary to chronic tophaceous gout with multilobular, solid, tender, enlarged subcutaneous nodules and draining tophi in both hands was evaluated and treated by second ray amputation of the most deformed second finger to provide a more...

  • Survey of Factor V Leiden and Prothrombin Gene Mutations in Systemic Lupus Erythematosus. Topaloglu, R.; Akierli, C.; Bakkaloglu, A.; Aydintug, O.; Ozen, S.; Besbas, N.; Ozcelik, T. // Clinical Rheumatology;Jul2001, Vol. 20 Issue 4, p259 

    : The two most common hereditary risk factors for thrombosis are factor V Leiden mutation and a prothrombin gene mutation. There is indeed a thrombotic tendency in patients with systemic lupus erythematosis (SLE) and it is not always associated with antiphospholipid antibodies. We aimed to...

  • Life-Threatening Complications of Hepatitis B Virus-Related Polyarteritis Nodosa Developing Despite Interferon-α2b Therapy: Successful Treatment with a Combination of Interferon, Lamivudine, Plasma Exchanges and Steroids. Deléaval, P.; Stadler, P.; Descombes, E.; Hecker, E.; Schrago, G.; Chizzolini, C.; Nicole, A.; Pugin, P.; Regamey, C. // Clinical Rheumatology;Jul2001, Vol. 20 Issue 4, p290 

    : Polyarteritis nodosa (PAN) is a rare vasculitis associated with hepatitis B virus (HBV) infection in a significant proportion of cases. When used to treat HBV-related PAN, immunosuppressive agents may enhance viral replication and relaspes are frequent. In recent years the use of antiviral...

  • Cerebral Atrophy Related to Corticotherapy in Systemic Lupus Erythematosus (SLE). Zanardi, V. A.; Magna, L. A.; Costallat, L. T. L. // Clinical Rheumatology;Jul2001, Vol. 20 Issue 4, p245 

    : The aim of this study was to evaluate the frequency and intensity of cerebral atrophy using CT scanning and the possible relation to corticosteroid therapy or disease in systemic lupus erythematosus (SLE) and to analyse the relationships between cerebral atrophy and activity disease and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics